
Sign up to save your podcasts
Or


A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.
By RBC Capital Markets5
1212 ratings
A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.

3,221 Listeners

1,708 Listeners

977 Listeners

1,855 Listeners

1,631 Listeners

1,083 Listeners

124 Listeners

324 Listeners

1,030 Listeners

1,290 Listeners

6,056 Listeners

34 Listeners

40 Listeners

20 Listeners

10 Listeners

1 Listeners

75 Listeners

19 Listeners

15 Listeners

3 Listeners